Andrew Steven Allegretti, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hepatorenal Syndrome | 19 | 2024 | 75 | 8.050 |
Why?
|
Acute Kidney Injury | 31 | 2024 | 1923 | 6.360 |
Why?
|
Liver Cirrhosis | 22 | 2024 | 1932 | 3.930 |
Why?
|
Vasoconstrictor Agents | 10 | 2024 | 654 | 2.600 |
Why?
|
Hemofiltration | 3 | 2023 | 59 | 2.050 |
Why?
|
Renal Replacement Therapy | 6 | 2024 | 281 | 1.650 |
Why?
|
Lypressin | 6 | 2024 | 26 | 1.410 |
Why?
|
Liver Transplantation | 11 | 2024 | 2329 | 1.250 |
Why?
|
Portasystemic Shunt, Transjugular Intrahepatic | 3 | 2021 | 96 | 1.240 |
Why?
|
Renal Insufficiency, Chronic | 14 | 2024 | 2254 | 1.080 |
Why?
|
Kidney Failure, Chronic | 8 | 2024 | 2478 | 1.080 |
Why?
|
Hypokalemic Periodic Paralysis | 1 | 2024 | 7 | 0.940 |
Why?
|
Thyrotoxicosis | 1 | 2024 | 85 | 0.880 |
Why?
|
Renal Dialysis | 5 | 2020 | 1796 | 0.820 |
Why?
|
Glomerular Filtration Rate | 10 | 2024 | 2181 | 0.790 |
Why?
|
Muscle Weakness | 1 | 2024 | 412 | 0.740 |
Why?
|
Micropore Filters | 1 | 2020 | 22 | 0.730 |
Why?
|
Glomerulonephritis, IGA | 1 | 2021 | 61 | 0.730 |
Why?
|
Biomarkers, Pharmacological | 1 | 2020 | 161 | 0.670 |
Why?
|
Pyrans | 1 | 2019 | 49 | 0.650 |
Why?
|
Patient Care Planning | 1 | 2024 | 904 | 0.610 |
Why?
|
Cholestasis | 1 | 2021 | 378 | 0.600 |
Why?
|
Angiopoietin-2 | 1 | 2019 | 173 | 0.590 |
Why?
|
Sickle Cell Trait | 4 | 2021 | 85 | 0.520 |
Why?
|
Paracentesis | 1 | 2016 | 98 | 0.510 |
Why?
|
Critical Illness | 4 | 2024 | 2709 | 0.490 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2016 | 282 | 0.490 |
Why?
|
Lectins | 1 | 2016 | 489 | 0.470 |
Why?
|
Drug Monitoring | 1 | 2020 | 961 | 0.460 |
Why?
|
Acid-Base Equilibrium | 1 | 2015 | 181 | 0.460 |
Why?
|
Anastomosis, Roux-en-Y | 1 | 2014 | 86 | 0.450 |
Why?
|
Bicarbonates | 1 | 2015 | 292 | 0.450 |
Why?
|
Waiting Lists | 3 | 2024 | 765 | 0.430 |
Why?
|
Heparin | 1 | 2020 | 1632 | 0.430 |
Why?
|
Liver Diseases | 1 | 2021 | 1300 | 0.410 |
Why?
|
Calciphylaxis | 1 | 2014 | 130 | 0.400 |
Why?
|
Kidney | 7 | 2023 | 7034 | 0.380 |
Why?
|
Tissue and Organ Harvesting | 1 | 2014 | 373 | 0.370 |
Why?
|
Hepatitis, Alcoholic | 2 | 2024 | 109 | 0.370 |
Why?
|
End Stage Liver Disease | 4 | 2024 | 352 | 0.350 |
Why?
|
Serum Albumin | 2 | 2024 | 674 | 0.350 |
Why?
|
Humans | 73 | 2024 | 761098 | 0.340 |
Why?
|
Living Donors | 1 | 2014 | 643 | 0.340 |
Why?
|
Intensive Care Units | 3 | 2023 | 3743 | 0.340 |
Why?
|
Hyponatremia | 2 | 2023 | 279 | 0.320 |
Why?
|
Prognosis | 12 | 2024 | 29672 | 0.320 |
Why?
|
Anemia, Sickle Cell | 3 | 2021 | 1063 | 0.290 |
Why?
|
Albumins | 2 | 2022 | 575 | 0.280 |
Why?
|
Middle Aged | 32 | 2024 | 220835 | 0.280 |
Why?
|
Male | 39 | 2024 | 360675 | 0.270 |
Why?
|
Chronic Disease | 3 | 2019 | 9317 | 0.260 |
Why?
|
Nurses | 1 | 2015 | 2476 | 0.250 |
Why?
|
Gastric Bypass | 1 | 2014 | 818 | 0.250 |
Why?
|
Aged | 27 | 2024 | 169266 | 0.240 |
Why?
|
Female | 37 | 2024 | 392458 | 0.230 |
Why?
|
Myelinolysis, Central Pontine | 1 | 2023 | 17 | 0.220 |
Why?
|
Severity of Illness Index | 8 | 2024 | 15845 | 0.220 |
Why?
|
Respiration, Artificial | 1 | 2015 | 2630 | 0.220 |
Why?
|
Obesity, Morbid | 1 | 2014 | 1277 | 0.210 |
Why?
|
Tremor | 1 | 2024 | 190 | 0.210 |
Why?
|
Hypokalemia | 1 | 2024 | 153 | 0.210 |
Why?
|
Creatinine | 2 | 2020 | 1897 | 0.210 |
Why?
|
Kidney Tubules, Proximal | 1 | 2024 | 382 | 0.200 |
Why?
|
Prospective Studies | 10 | 2024 | 54419 | 0.200 |
Why?
|
Taste Disorders | 1 | 2022 | 38 | 0.200 |
Why?
|
Low Back Pain | 1 | 2010 | 983 | 0.190 |
Why?
|
Epidermal Growth Factor | 1 | 2024 | 699 | 0.190 |
Why?
|
Liver Failure | 1 | 2024 | 250 | 0.190 |
Why?
|
Kidney Tubular Necrosis, Acute | 1 | 2021 | 65 | 0.190 |
Why?
|
Exercise | 1 | 2018 | 5872 | 0.190 |
Why?
|
Liver Cirrhosis, Alcoholic | 1 | 2021 | 64 | 0.180 |
Why?
|
Feces | 2 | 2017 | 1490 | 0.180 |
Why?
|
Arm | 1 | 2024 | 589 | 0.180 |
Why?
|
Clostridium Infections | 2 | 2017 | 557 | 0.180 |
Why?
|
Treatment Outcome | 10 | 2024 | 64670 | 0.180 |
Why?
|
Receptors, Purinergic P2Y | 1 | 2020 | 23 | 0.180 |
Why?
|
Kidney Transplantation | 2 | 2021 | 4240 | 0.180 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2015 | 4013 | 0.180 |
Why?
|
Vancomycin | 1 | 2023 | 503 | 0.180 |
Why?
|
Adult | 22 | 2024 | 221083 | 0.170 |
Why?
|
Ferrosoferric Oxide | 1 | 2021 | 348 | 0.170 |
Why?
|
Factor Xa | 1 | 2020 | 166 | 0.170 |
Why?
|
Physicians | 2 | 2015 | 4583 | 0.170 |
Why?
|
Clinical Competence | 1 | 2015 | 4786 | 0.170 |
Why?
|
Olfaction Disorders | 1 | 2022 | 224 | 0.160 |
Why?
|
Esophageal and Gastric Varices | 1 | 2021 | 208 | 0.160 |
Why?
|
Leg | 1 | 2024 | 1087 | 0.160 |
Why?
|
Hypertension, Portal | 1 | 2021 | 227 | 0.160 |
Why?
|
Bile Acids and Salts | 1 | 2021 | 393 | 0.160 |
Why?
|
Diagnosis, Differential | 3 | 2024 | 12975 | 0.150 |
Why?
|
Thyroidectomy | 1 | 2024 | 908 | 0.150 |
Why?
|
Communication | 2 | 2024 | 3852 | 0.150 |
Why?
|
Fibrosis | 2 | 2023 | 2051 | 0.150 |
Why?
|
Equipment Failure Analysis | 1 | 2020 | 846 | 0.150 |
Why?
|
Sodium | 2 | 2023 | 1589 | 0.150 |
Why?
|
Retrospective Studies | 13 | 2024 | 80673 | 0.150 |
Why?
|
Health Resources | 1 | 2024 | 934 | 0.150 |
Why?
|
Cohort Studies | 8 | 2024 | 41486 | 0.140 |
Why?
|
DNA, Bacterial | 2 | 2019 | 1470 | 0.140 |
Why?
|
Physician-Patient Relations | 1 | 2010 | 3238 | 0.140 |
Why?
|
Massachusetts | 3 | 2019 | 8836 | 0.140 |
Why?
|
Attitude of Health Personnel | 1 | 2010 | 3882 | 0.130 |
Why?
|
Case-Control Studies | 5 | 2024 | 22157 | 0.130 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2019 | 12145 | 0.120 |
Why?
|
Risk Factors | 9 | 2024 | 74219 | 0.120 |
Why?
|
Clinical Protocols | 1 | 2020 | 1436 | 0.120 |
Why?
|
Liver Failure, Acute | 1 | 2016 | 181 | 0.120 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2024 | 1081 | 0.120 |
Why?
|
Elastic Modulus | 1 | 2015 | 211 | 0.120 |
Why?
|
Blood Coagulation | 1 | 2020 | 1156 | 0.120 |
Why?
|
Disease Progression | 5 | 2023 | 13506 | 0.120 |
Why?
|
Magnetic Resonance Angiography | 1 | 2021 | 1432 | 0.110 |
Why?
|
Proxy | 1 | 2015 | 151 | 0.110 |
Why?
|
Poison Control Centers | 1 | 2014 | 76 | 0.110 |
Why?
|
Carrier State | 1 | 2017 | 522 | 0.110 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 2017 | 335 | 0.110 |
Why?
|
Length of Stay | 2 | 2020 | 6420 | 0.110 |
Why?
|
Anemia | 1 | 2023 | 1504 | 0.110 |
Why?
|
Diagnostic Errors | 1 | 2020 | 1265 | 0.110 |
Why?
|
Hemoglobins | 1 | 2019 | 1525 | 0.110 |
Why?
|
Bumetanide | 1 | 2013 | 98 | 0.110 |
Why?
|
Hospital Mortality | 2 | 2020 | 5296 | 0.100 |
Why?
|
Weight Loss | 1 | 2024 | 2680 | 0.100 |
Why?
|
Poisoning | 1 | 2014 | 252 | 0.100 |
Why?
|
Hospital Charges | 1 | 2014 | 350 | 0.100 |
Why?
|
Postoperative Complications | 1 | 2014 | 15634 | 0.100 |
Why?
|
Ischemia | 1 | 2020 | 1889 | 0.100 |
Why?
|
Dietary Supplements | 1 | 2024 | 3410 | 0.090 |
Why?
|
Hip Fractures | 1 | 2019 | 989 | 0.090 |
Why?
|
Ascites | 2 | 2024 | 338 | 0.090 |
Why?
|
Abdominal Pain | 1 | 2017 | 1071 | 0.090 |
Why?
|
Diarrhea | 1 | 2017 | 1318 | 0.090 |
Why?
|
Carbon Dioxide | 1 | 2015 | 1148 | 0.090 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2015 | 2478 | 0.090 |
Why?
|
Diuretics | 1 | 2013 | 611 | 0.090 |
Why?
|
Patient Acceptance of Health Care | 1 | 2024 | 3197 | 0.090 |
Why?
|
Fatal Outcome | 1 | 2014 | 1837 | 0.080 |
Why?
|
Neoplasms | 1 | 2018 | 22125 | 0.080 |
Why?
|
Muscle, Skeletal | 1 | 2024 | 4947 | 0.080 |
Why?
|
Survival Analysis | 1 | 2021 | 10083 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10755 | 0.080 |
Why?
|
Antihypertensive Agents | 1 | 2017 | 2019 | 0.070 |
Why?
|
Time Factors | 3 | 2024 | 39953 | 0.070 |
Why?
|
Hemorrhage | 1 | 2019 | 3422 | 0.070 |
Why?
|
Reproducibility of Results | 2 | 2023 | 20120 | 0.070 |
Why?
|
Patient Readmission | 1 | 2020 | 3268 | 0.060 |
Why?
|
Anti-Bacterial Agents | 1 | 2023 | 7405 | 0.060 |
Why?
|
Double-Blind Method | 1 | 2019 | 12341 | 0.060 |
Why?
|
United States | 6 | 2024 | 72337 | 0.060 |
Why?
|
Anticoagulants | 1 | 2020 | 4795 | 0.060 |
Why?
|
Models, Statistical | 1 | 2019 | 5077 | 0.060 |
Why?
|
Health Status | 1 | 2017 | 4077 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2023 | 5841 | 0.060 |
Why?
|
Patients | 1 | 2010 | 906 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2017 | 10213 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12058 | 0.050 |
Why?
|
Comorbidity | 1 | 2017 | 10514 | 0.050 |
Why?
|
Interviews as Topic | 1 | 2010 | 2696 | 0.050 |
Why?
|
Sepsis | 1 | 2016 | 2586 | 0.050 |
Why?
|
Age Factors | 1 | 2019 | 18385 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12467 | 0.050 |
Why?
|
Hypertension | 1 | 2022 | 8537 | 0.050 |
Why?
|
Hospitalization | 2 | 2024 | 10712 | 0.050 |
Why?
|
Pandemics | 1 | 2020 | 8663 | 0.040 |
Why?
|
Patient-Centered Care | 1 | 2010 | 1424 | 0.040 |
Why?
|
Hemoglobin, Sickle | 1 | 2019 | 113 | 0.040 |
Why?
|
Survival Rate | 3 | 2024 | 12727 | 0.040 |
Why?
|
Necrosis | 1 | 2023 | 1611 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 2 | 2024 | 36418 | 0.040 |
Why?
|
Extracellular Fluid | 1 | 2019 | 165 | 0.040 |
Why?
|
Midodrine | 1 | 2017 | 24 | 0.040 |
Why?
|
Indiana | 1 | 2017 | 92 | 0.040 |
Why?
|
Neutrophil Infiltration | 1 | 2020 | 390 | 0.040 |
Why?
|
Aged, 80 and over | 4 | 2019 | 58946 | 0.040 |
Why?
|
Cardiovascular Diseases | 2 | 2024 | 15513 | 0.040 |
Why?
|
Europe | 1 | 2024 | 3422 | 0.040 |
Why?
|
Cytoskeleton | 1 | 2022 | 1169 | 0.030 |
Why?
|
Octreotide | 1 | 2017 | 154 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39121 | 0.030 |
Why?
|
Chemokines | 1 | 2020 | 956 | 0.030 |
Why?
|
Gadolinium | 1 | 2021 | 961 | 0.030 |
Why?
|
Metagenomics | 1 | 2019 | 463 | 0.030 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2019 | 1032 | 0.030 |
Why?
|
Urinalysis | 1 | 2017 | 368 | 0.030 |
Why?
|
Norepinephrine | 1 | 2017 | 898 | 0.030 |
Why?
|
Consensus | 1 | 2024 | 3133 | 0.030 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2021 | 1116 | 0.030 |
Why?
|
International Classification of Diseases | 1 | 2019 | 913 | 0.030 |
Why?
|
Pilot Projects | 2 | 2019 | 8639 | 0.030 |
Why?
|
Genes, Bacterial | 1 | 2017 | 1073 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2023 | 3210 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 26068 | 0.030 |
Why?
|
Elasticity | 1 | 2015 | 655 | 0.030 |
Why?
|
Nephrotic Syndrome | 1 | 2017 | 382 | 0.030 |
Why?
|
International Cooperation | 1 | 2018 | 1423 | 0.030 |
Why?
|
Acute Disease | 1 | 2023 | 7240 | 0.020 |
Why?
|
RNA | 1 | 2022 | 2708 | 0.020 |
Why?
|
Patient Selection | 1 | 2024 | 4245 | 0.020 |
Why?
|
Treatment Failure | 1 | 2017 | 2643 | 0.020 |
Why?
|
Monocytes | 1 | 2020 | 2570 | 0.020 |
Why?
|
HIV Infections | 1 | 2017 | 17349 | 0.020 |
Why?
|
Recovery of Function | 1 | 2021 | 2981 | 0.020 |
Why?
|
Point-of-Care Systems | 1 | 2019 | 1213 | 0.020 |
Why?
|
Elasticity Imaging Techniques | 1 | 2015 | 389 | 0.020 |
Why?
|
Dopamine | 1 | 2017 | 1606 | 0.020 |
Why?
|
Mortality | 1 | 2021 | 2896 | 0.020 |
Why?
|
Colonoscopy | 1 | 2017 | 1398 | 0.020 |
Why?
|
Cost Savings | 1 | 2014 | 912 | 0.020 |
Why?
|
Risk Assessment | 2 | 2021 | 24013 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2013 | 2217 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2017 | 6067 | 0.020 |
Why?
|
Contrast Media | 1 | 2021 | 5311 | 0.020 |
Why?
|
Neutrophils | 1 | 2020 | 3763 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2019 | 3568 | 0.020 |
Why?
|
Kidney Diseases | 1 | 2017 | 2092 | 0.020 |
Why?
|
Recurrence | 1 | 2017 | 8456 | 0.020 |
Why?
|
Incidence | 1 | 2023 | 21357 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2020 | 14393 | 0.010 |
Why?
|
Sex Factors | 1 | 2019 | 10552 | 0.010 |
Why?
|
Prevalence | 1 | 2022 | 15717 | 0.010 |
Why?
|
Ultrasonography | 1 | 2017 | 5971 | 0.010 |
Why?
|
Registries | 1 | 2019 | 8236 | 0.010 |
Why?
|
Young Adult | 2 | 2019 | 59199 | 0.010 |
Why?
|
Adolescent | 2 | 2019 | 88271 | 0.010 |
Why?
|
Algorithms | 1 | 2018 | 14023 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 1992 | 6340 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2014 | 26187 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2017 | 20600 | 0.010 |
Why?
|
Mice | 1 | 2020 | 81324 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 1992 | 6919 | 0.010 |
Why?
|
Infant | 1 | 2014 | 36164 | 0.010 |
Why?
|
Child, Preschool | 1 | 2014 | 42217 | 0.010 |
Why?
|
Animals | 1 | 2020 | 168083 | 0.000 |
Why?
|
Child | 1 | 2014 | 80134 | 0.000 |
Why?
|